Elon Musk-founded biotech company Neuralink has closed a $280 million Series D funding round.
The main investor was the Peter Thiel Founders Fund, which supported SpaceX, Stripe, Paxos and other large organizations.
Neuralink was founded in 2016 in California with the participation of Musk. The firm develops digital interfaces implanted in the human brain that provide direct communication with various devices.
The company did not specify what the proceeds will be used for. However, the main goal of the company is to help people with paralysis or other neurological diseases. Neuralink technologies allow you to interact with computers using neural activity.
The project has a separate staff of surgeons who are currently training on accurate head models of potential patients.
After the announcement of the attraction of funding, the company also announced new open vacancies. Neuralink is looking for engineers, IT professionals and cybersecurity experts.
The firm has previously faced criticism for testing its technology on animals. In May 2023, several US senators wrote a letter demanding an appropriate investigation.
Until recently, Neuralink has been testing monkeys and pigs. In 2021, scientists showed a macaque playing the old video game Pong using a brain chip.
In May of this year, Neuralink received approval FDA for clinical trials in humans.
Recall that in January, Neuralink opened a vacancy for the director of clinical trials.
That same month, Elon Musk promised to prevent the rise of the machines.
Found a mistake in the text? Select it and press CTRL+ENTER
ForkLog Newsletters: Keep your finger on the pulse of the bitcoin industry!